Teladoc Health Inc buy Barclays PLC
Start price
21.02.24
/
50%
€14.32
Target price
21.02.25
€23.12
Performance (%)
-48.97%
Price
13.09.24
€7.31
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Teladoc Health Inc is performing very badly with a performance of -48.97%. This prediction currently runs until 21.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | 7.805% | 7.805% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Barclays_PLC for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Barclays PLC from $26.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Barclays_PLC for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€8.34
01.08.24
01.08.24
€9.27
01.08.25
01.08.25
-12.39%
13.09.24
13.09.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.43
26.04.24
26.04.24
€18.73
26.04.25
26.04.25
-41.23%
13.09.24
13.09.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€19.55
03.01.24
03.01.24
€23.81
03.01.25
03.01.25
-62.62%
13.09.24
13.09.24